PurMacept™ Lab Surface Sanitizer (10X) is a proprietary two-component disinfectant from PurMa Biologics, developed from over 20 years of laboratory experience. When diluted and mixed, its components generate free radicals that rapidly eliminate a broad spectrum of contaminants — bacteria, fungi/yeast, viruses (including SARS-CoV-2), and mycoplasma — making it especially suited for cell culture and other sensitive laboratory environments. The free radicals persist for approximately two weeks as they are released gradually; therefore, prepare quantities that maximize use within this period and remix every two weeks. (Claim based on internal stability testing; subject to site validation.)
Background
Alcohol-based sanitizers (most commonly isopropanol) are widely used in laboratories due to low cost and ease of use. However, repeated or prolonged inhalation exposure — particularly in enclosed or poorly ventilated settings such as biosafety cabinets or small labs — carries documented occupational risks, including chronic respiratory irritation, neurocognitive effects (memory and concentration deficits, sleep disturbances, mood changes), potential neurotoxicity with high cumulative exposure, hepatic and renal strain, owing to metabolic burden, sensory impairment, exacerbation of preexisting respiratory or CNS conditions, and indirect dermal effects from vapor condensation. PurMacept™ has been formulated for safe use by personnel in enclosed areas when used according to instructions and PPE guidance.
Superior Mechanism of Action
- Free-radical oxidative elimination: Upon activation, PurMacept™ generates reactive free radicals that induce multi-target oxidative damage to microbial components.
- Cell wall and membrane disruption: For organisms with cell walls, PurMacept™ destroys the cell wall and membrane, causing lysis and elimination.
- Mycoplasma elimination: For mycoplasma (which lack a cell wall), PurMacept™ disrupts the cell membrane and penetrates intracellularly to oxidatively damage nucleoid DNA/RNA and essential macromolecules, resulting in complete elimination.
Broad-Spectrum, Rapid Efficacy
- Short required contact times to minimize workflow disruption.
- Demonstrated activity against Gram-positive and Gram-negative bacteria, molds/yeasts, enveloped viruses (including SARS-CoV-2), and mycoplasma.
- Reduced microbial rebound due to multi-target oxidative action.
Practical Advantages in the Laboratory
- Concentrated, cost-effective 10X format (dilute 1:10).
- If applied twice to a surface, residual activity of PurMacept™ helps prevent regrowth of common laboratory pathogens. (Claim subject to validation and routine environmental monitoring.)
- Two-component, on-demand activation improves storage stability and assures potency at application.
- Compatible with routine decontamination workflows for incubators, biosafety cabinets, benches, and other hard, non-porous surfaces.
- Formulated for personnel safety when used with appropriate PPE and handling procedures.
Comparative Benefits versus Common Sanitizers
- Improved mycoplasma control relative to quaternary ammonium compounds and alcohols.
- Less corrosive and more stable than sodium hypochlorite (bleach) or pre-mixed oxidizers.
- Broad coverage reduces the need for multiple specialized products.
Validated Mycoplasma Control and Escalation
- Optimized for reliable mycoplasma elimination in routine environmental control.
- For severe or persistent contamination, use PurMa™ MycoSpray (Cat#: P5M010405) as a targeted follow-up intervention.
Usage Recommendations
- Dilution: Prepare working solution by diluting PurMacept™ concentrate 1:10 (1 part concentrate to 9 parts water) and mix components per label instructions.
- Application: Apply by spray, wipe, or mop; ensure the recommended contact time is achieved before wiping or allowing surfaces to air dry.
- PPE and controls: Use gloves and eye protection; ensure adequate ventilation and follow institutional chemical handling and disposal policies. Consult the SDS for complete safety information.
Conclusion
Built on two decades of PurMa Biologics’ expertise, PurMacept™ Lab Surface Sanitizer (10X) delivers a robust and laboratory-appropriate solution for eliminating contaminants in cell culture environments. Its two-component free-radical chemistry destroys cell walls and membranes and penetrates intracellular targets in mycoplasma, ensuring comprehensive elimination while supporting routine lab workflows and personnel safety.